← All Abvc Biopharma, INC filings

Abvc Biopharma, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
ABVC
Abvc Biopharma, INC
S-1: ABVC BioPharma Files for Resale of 1 Million Shares Underlying Common Stock Purchase Warrant
ABVC BioPharma is registering for the resale of up to 1,000,000 shares of its common stock underlying a warrant held by a selling stockholder.
NASDAQ
ABVC
Abvc Biopharma, INC
S-1/A: ABVC BioPharma Files Amendment No. 3 to Form S-1 Registration Statement
ABVC BioPharma files an amendment to its Form S-1 registration statement to include information from its 2023 Annual Report on Form 10-K, pertaining to the resale of up to 11,714,683 shares of common stock by selling stockholders.
NASDAQ
ABVC
Abvc Biopharma, INC
S-1/A: ABVC BioPharma Files Amendment No. 2 to Form S-1 Registration Statement
ABVC BioPharma files an amendment to its registration statement related to the resale of up to 11,714,683 shares of common stock by selling stockholders.
NASDAQ
ABVC
Abvc Biopharma, INC
S-1/A: ABVC BioPharma Eyes Resale of Up to 11.7 Million Shares Amid Financial Restructuring
ABVC BioPharma is registering for resale up to 11.7 million shares of its common stock, primarily related to convertible notes and warrants issued to Lind Global Fund II, LP, as part of ongoing financial transactions.
NASDAQ
ABVC
Abvc Biopharma, INC
S-1: ABVC BioPharma Eyes Resale of Over 10 Million Shares Amid Ongoing Development
ABVC BioPharma is registering for the resale of over 10 million shares of its common stock by selling stockholders, as detailed in a recent S-1 filing.